ALEJANDRO DIAZ
Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Endocrinology MIAMI, FL NPI 1821185869
Browse related groups: Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Endocrinology FL GENZYME CORPORATION All categories
General Payments — all program years on this page
$26,048.01
- Category: General Payments
- Program years: PY2018–2024
- Record count: 408
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $12,201.77 across 63 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $9,815.00 | 1 |
| Food and Beverage | $2,342.73 | 61 |
| Travel and Lodging | $44.04 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| GENZYME CORPORATION | $10,122.51 | 4 |
| Novo Nordisk AS | $401.61 | 10 |
| SANOFI-AVENTIS U.S. LLC | $351.06 | 13 |
| Neurocrine BioSciences, Inc. | $202.32 | 3 |
| BETA BIONICS, INC. | $195.03 | 5 |
| Ascendis Pharma Inc | $170.37 | 3 |
| Rhythm Pharmaceuticals, Inc. | $137.10 | 2 |
| Eton Pharmaceuticals, Inc. | $108.32 | 1 |
| Tandem Diabetes Care, Inc. | $93.29 | 1 |
| Xeris Pharmaceuticals, Inc. | $61.35 | 3 |
| PFIZER INC. | $58.83 | 3 |
| Insulet Corporation | $47.54 | 2 |
| DEXCOM, INC. | $41.16 | 2 |
| Amphastar Pharmaceuticals, Inc. | $38.36 | 2 |
| Abbott Laboratories | $22.97 | 1 |
| Kyowa Kirin, Inc. | $21.67 | 1 |
| Endo USA, Inc. | $20.43 | 1 |
| ABBVIE INC. | $19.38 | 1 |
| Azurity Pharmaceuticals, Inc. | $19.23 | 1 |
| Medtronic, Inc. | $18.73 | 1 |
| Alexion Pharmaceuticals, Inc. | $18.49 | 1 |
| Endo Pharmaceuticals Inc. | $17.38 | 1 |
| Amneal Pharmaceuticals LLC | $14.64 | 1 |
By program year
Records — PY2024 (63)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.